Karo Pharma Aktiebolag announced earnings results for the second quarter and year to date of 2021. For the quarter, the company reported revenues of PLN 164.9 million a decrease of 2.8% year on year. EBIT was PLN 38.7 million, an increase of 38.7% year on year. Attributable net profit of PLN 33.4 million, an increase of 30.5%. For the year to date, the company reported revenues of PLN 339.0 million a decrease of 28.1% year on year. EBIT was PLN 94.6 million, an increase of 41.2% year on year. Attributable net profit of PLN 86.1 million, an increase of 41.3%.